as 07-26-2024 4:00pm EST
Insulet was founded in 2000 with the goal of making continuous subcutaneous insulin infusion therapy for diabetes easier to use. The result was the Omnipod system, which consists of a small disposable insulin infusion device and that can be operated through a smartphone to control dosage. Since the Omnipod was approved by the U.S. Food and Drug Administration in 2005, approximately 425,000 insulin-dependent diabetics are using it worldwide.
Founded: | 2000 | Country: | United States |
Employees: | N/A | City: | ACTON |
Market Cap: | 13.4B | IPO Year: | 2007 |
Target Price: | $238.53 | AVG Volume (30 days): | 593.0K |
Analyst Decision: | Strong Buy | Number of Analysts: | 17 |
Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
EPS: | 3.33 | EPS Growth: | 33200.00 |
52 Week Low/High: | $125.82 - $283.00 | Next Earning Date: | 08-08-2024 |
Revenue: | $1,780,700,000 | Revenue Growth: | 30.17% |
Revenue Growth (this year): | 19.03% | Revenue Growth (next year): | 18.37% |
Name | Ticker | Relationship | Date | Transaction | Cost Per Share | Shares | Total Value | Securities Owned After Transaction(s) | SEC Form 4 |
---|---|---|---|---|---|---|---|---|---|
Field Mark N | PODD | SVP & Chief Technology Officer | Jun 14 '24 | Sell | $199.96 | 1,500 | $299,940.00 | 12,875 | SEC Form 4 |
Field Mark N | PODD | SVP & Chief Technology Officer | Jun 10 '24 | Sell | $190.43 | 2,131 | $405,806.33 | 14,375 | SEC Form 4 |
BORIO LUCIANA | PODD | Director | Jun 4 '24 | Sell | $182.58 | 360 | $65,728.80 | 3,298 | SEC Form 4 |
Scannell Timothy J | PODD | Director | May 28 '24 | Sell | $180.90 | 3,300 | $596,970.00 | 42,586 | SEC Form 4 |
Petrovic Shacey | PODD | Director | Feb 28 '24 | Sell | $162.92 | 11,609 | $1,891,338.28 | 2,567 | SEC Form 4 |
BORIO LUCIANA | PODD | Director | Dec 15 '23 | Sell | $207.08 | 72 | $14,909.76 | 2,278 | SEC Form 4 |
Petrovic Shacey | PODD | Director | Nov 13 '23 | Sell | $165.02 | 2,075 | $342,416.50 | 41,130 | SEC Form 4 |
Petrovic Shacey | PODD | Director | Nov 13 '23 | Sell | $165.02 | 12,925 | $2,132,883.50 | 0 | SEC Form 4 |
Petrovic Shacey | PODD | Director | Nov 13 '23 | Sell | $164.33 | 20,000 | $3,286,600.00 | 2,567 | SEC Form 4 |
PODD Breaking Stock News: Dive into PODD Ticker-Specific Updates for Smart Investing
The Wall Street Journal
10 hours ago
MT Newswires
11 hours ago
Business Wire
14 hours ago
Zacks
8 days ago
Simply Wall St.
14 days ago
Business Wire
19 days ago
Barrons.com
a month ago
Zacks
a month ago
The information presented on this page, "PODD Insulet Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.